(Q30580226)

25 June 2017

title

Safety profile of belimumab: pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosus (English)

1 reference

systemic lupus erythematosus

25 June 2017

0 references

1 reference

0 references

7

R A Levy

1 reference

25 June 2017

Ricard Cervera i Segura

12

object named as

R Cervera

1 reference

25 June 2017

3

M A Petri

1 reference

25 June 2017

D J Wallace

1

1 reference

25 June 2017

S Navarra

2

1 reference

25 June 2017

A Gallacher

4

1 reference

25 June 2017

M Thomas

5

1 reference

25 June 2017

R Furie

6

1 reference

25 June 2017

R F van Vollenhoven

8

1 reference

25 June 2017

S Cooper

9

1 reference

25 June 2017

Z J Zhong

10

1 reference

25 June 2017

W Freimuth

11

1 reference

25 June 2017

BLISS-52 and -76, and LBSL02 Study Groups

13

1 reference

25 June 2017

publication date

4 December 2012

1 reference

25 June 2017

1 reference

25 June 2017

volume

22

1 reference

25 June 2017

issue

2

1 reference

25 June 2017

page(s)

144-154

1 reference

The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus

25 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469259

Systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469259

Mortality in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469259

Two aspects of the clinical and humanistic burden of systemic lupus erythematosus: mortality risk and quality of life early in the course of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469259

Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469259

Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469259

Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469259

Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469259

Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469259

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469259

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469259

A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469259

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469259

Infections in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469259

An international cohort study of cancer in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469259

Malignancies in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469259

Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469259

Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469259

Maternal and fetal outcome of lupus pregnancy: a prospective study of 29 pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469259

The impact of increased lupus activity on obstetric outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469259

Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: An international inception cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203312469259

21 January 2018

Identifiers

DOI

10.1177/0961203312469259

1 reference

25 June 2017

1 reference